Food and Drug Administration advisers on Wednesday enthusiastically endorsed a first-of-its-kind cancer treatment that uses patients’ revved-up immune cells to fight the disease, concluding that the therapy’s benefits for desperately ill children far outweigh its potentially dangerous side effects.
What's Trending in the Molecular World
Bedside production of protein drugs could help payers by lowering drug prices. It may ultimately lead to individualized treatments. Read more here.
As whiskey takes off in popularity around the globe, con artists aren’t far behind. Read more here.
When doctors saw the report on Bill Ludwig’s bone-marrow biopsy, they thought it was a mistake and ordered the test repeated. Read more here.
Crispr Patent-Holders Move Toward Easing Access to Gene-Editing Technology Read more here.
Genetic map showing how dog breeds are related provides a wealth of information about their origins. Read more here.